AlphaYouDM
Insider selling
David Malcom Rodman sold $59K of Mineralys Therapeutics, Inc. (MLYS) stock
David Malcom Rodman, Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS), sold 2,170 shares of MLYS stock worth $59K, per an SEC Form 4 filed Aug 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 10, 2026, 2 days before it was made public.
MLYS has moved +3.4% since the trade date, from $27.38 to $28.31 (Sep 21, 2026 close).
- Traded
- Aug 10, 2026
- Disclosed
- Aug 12, 2026
- Filing delay
- 2 days
- Price since
- +3.4%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More MLYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.